PF-07295324

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07295324, covering 2024-11-14 to 2024-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955 [Phase 1]